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INTRODUCTION
The preclinical large animal study is one of the most impor-
tant aspects of the assessment of a new valvular prosthesis (1).
An appropriate animal model must be large enough to accom-
modate devices that can be implanted in humans, as both
size and geometry influence the fluid mechanics (2). In the
testing of aortic valvular prostheses in animals, the heterotopic
mitral position has been the most frequently tested site, be-
cause direct aortic implantation is technically demanding.
However, incongruities in the quality of hemodynamic stres-
sors of the aortic and mitral positions exist, and the hemody-
namic data derived from the mitral position may not neces-
sarily represent the aortic position. Furthermore, for testing
in the mitral position, not only is cardio-pulmonary bypass
a prerequisite, but trained persons that can deal with the com-
plexities and operation of these machines are required to be
in attendance (4); all of which may add to excessive cost. To
address these shortcomings, the current study was devised
to develop a simple, safe, and cost efficient large animal model
for performing site specific hemodynamic assessments in the
aortic environment.
MATERIALS AND METHODS
Animals and preoperative preparation
Ten castrated male Hampshire swine, weighing 52.4±6
kg (40-60 kg) were used. The protocol used in this study
was approved by the Animal Use and Care committee of the
University of Ulsan. All animals received humane care in com-
pliance with the principles stated in the Guide for Care and
Use of Laboratory Animals (NIH Publication No. 85-23).
From 12 hr before surgery, the animals were given free access
to only water. The animals were sedated with an intramuscular
injection of ketamine HCl (10-15 mg/kg) and placed in the
supine position on the operating table. A blanket roll was
Suk Jung Choo, Kun Il Kim,
Nam Hee Park, Jong Min Song*,
In Cheol Choi
� , Jee Yeon Shim
� ,
Sang Kwon Lee, Young Joo Kwon
� ,
Chang Nyung Kim
�, Jae Won Lee
Department of Thoracic & Cardiovascular Surgery, Asan
Medical Center, University of Ulsan, Seoul; *Department
of Internal Medicine, Division of Cardiology, Asan
Medical Center, University of Ulsan, Seoul; 
� Department
Anesthesia, Asan Medical Center, University of Ulsan,
Seoul; 
� Department of Mechano-Informatics & Design 
Engineering, College of Science and Technology,
Hongik University; 
�College of Mechanical and 
Industrial System Engineering, Kyunghee University
Seoul, Korea
Address for correspondence
Jae Won Lee, M.D.
Department of Thoracic & Cardiovascular Surgery,
Asan Medical Center, University of Ulsan, College of
Medicine, 388-1 Poongnap-dong, Songpa-gu, Seoul
138-040, Korea
Tel : +82.2-3010-3580, Fax : +82.2-3010-6966
E-mail : jwlee@amc.seoul.kr
*This work was supported by The Korea Research
Foundation Grant (KRF-99-042-F00127-F3300).
37
J Korean Med Sci 2004; 19: 37-41
ISSN 1011-8934
Copyright � The Korean Academy
of Medical Sciences
Development of an Animal Experimental Model for a Bileaflet
Mechanical Heart Valve Prosthesis
The objective of this study was to develop a pre-clinical large animal model for the
in vivo hemodynamic testing of prosthetic valves in the aortic position without the
need for cardiopulmonary bypass. Ten male pigs were used. A composite valved
conduit was constructed in the operating room by implanting a prosthetic valve
between two separate pieces of vascular conduits, which bypassed the ascending
aorta to the descending aorta. Prior to applying a side-biting clamp to the ascending
aorta for proximal grafting to the aortic anastomosis, an aorta to femoral artery
shunt was placed just proximally to this clamp. The heart rate, cardiac output,
Vmax, transvalvular pressure gradient, effective orifice area and incremental dobu-
tamine stress response were assessed. A dose dependant increase with dobu-
tamine was seen in terms of cardiac output, Vmax, and the peak transvalvular pres-
sure gradient both in the native and in the prosthetic valve. However, the increment
was much steeper in the prosthetic valve. No significant differences in cardiac
output were noted between the native and the prosthetic valves. The described
pre-clinical porcine model was found suitable for site-specific in-vivo hemodynamic
assessment of aortic valvular prosthesis without cardiopulmonary bypass.
Key Words : Surgical instruments; Prosthetic Valve; Cardiopulmonary Bypass; Hemodynamic Assess-
ment; Hemodynamic Processes
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Accepted : 15 October 2003used to aid thermoregulation. Electrocardiographic leads were
positioned for continuous monitoring, and external defibril-
lation patches were placed on the back for emergent cardiac
defibrillation. An additional intermittent infusion of ketamine
was given intravenously via an ear vein as needed. Intubation
for ventilator support was established by tracheostomy. General
anesthesia was maintained with pancuronium bromide (2-4
mg/hr) and 1-3% enflurane. PaCO2 was maintained below
40 mmHg. Upon completing the experiment, the pigs were
euthanized with a fatal intracardiac injection of saturated
potassium chloride while under anesthesia.
Operative procedures
The pulmonary arterial pressure and cardiac output were
monitored every 30 min with a Swan-Ganz catheter passed
through the right internal jugular vein. Before opening the
sternum, continuous arterial pressure monitoring was estab-
lished through the right femoral artery, and through the left
internal thoracic artery after sternotomy. The arterial pressure
was continuously monitored and maintained at a mean level
of 70 mmHg. To access the mediastinal structures, a standard
median sternotomy was performed from the sternal notch to
the xyphoid process level. For simultaneous exposure of the
descending thoracic aorta, an L shaped lateral extension was
made leftward from the distal tip of the sternotomy. Two indi-
vidual vascular conduits of internal diameter 21 mm and
length 30 cm were used to construct the composite valved
conduit. The prosthetic valve, a 17 mm St. Jude HPJ 505
mechanical aortic heart valve (St. Jude Medical Europe, Brus-
sels, Belgium), was sutured to the distal end of the conduit
with continuous running suture of polypropylene #4-0. A
0.5 cm curtain of the vascular graft material was left distal
to the prosthetic valve implantation site. The second graft
conduit was sutured in an end to end fashion with #4-0 poly-
propylene continuous running suture, to the curtain of graft
material distal to the prosthetic graft (Fig. 1). Basically, the
vascular conduit was selected to closely match that of the pros-
thetic valve being tested in size. The conduit was sufficiently
large to accommodate the slight variations in the external
prosthetic valvular diameter that is seen among different man-
ufacturers for any given valve size. Heparin 100 units/kg was
administered intravenously for anticoagulation. A 21 Fr ped-
iatric arterial perfusion cannula was connected to each end
of a 3/8 inch diameter silicone tubing of 1 meter in length to
construct an aorta to femoral artery bypass perfusion shunt.
After separating the main pulmonary artery and the ascending
aorta a braided nylon umbilical tape was passed under the
ascending aorta with the aid of a right-angled Kelly. A single
purse-string suture was created just distal to the non-coronary
sinus with a braided multifilament #1-0 suture on the pos-
terior aspect of the ascending aorta by pulling on the umbil-
ical tape. The proximal femoral artery was then exposed for
distal cannulation of the shunt. When the activated coagula-
tion time exceeded 200 sec, the ascending aorta was shunted
to the femoral artery with the silicone shunt, as described
above. After ensuring good functioning of the aorta to femoral
artery shunt, the ascending aorta was partially clamped with
a side-biting Satinsky clamp just distal to the aorto-femoral
shunt. The proximal end of the composite graft was anasto-
mosed to the side clamped portion of the ascending aorta in
an end- to-side fashion with a #4-0 polypropylene running
suture. Due to the short length of the ascending aorta, clamp-
ing of the innominate artery together with the ascending aorta
with the side-biting clamp was unavoidable. Consequently,
the innominate artery was partially included in the proximal
anastomosis between the ascending aorta and the composite
valved conduit. The distal end of the composite valved con-
duit was anastomosed in and end-to side manner to the dis-
tal descending aorta at the diaphragmatic crux level with a
continuous running suture of 4-0 polypropylene. Hemody-
namic assessment of the native aortic valve was performed
before cross clamping the proximal descending thoracic aorta,
whereas assessment of the prosthetic aortic valve was performed
after cross clamping the proximal descending thoracic aorta.
Arterial pressure was monitored directly through the internal
mammary and the femoral arteries as described above. The
purpose of monitoring through the internal mammary artery
was to check the arterial pressure during the cross clamping
of the proximal descending thoracic aorta.
Hemodynamic assessment
Echocardiography was performed using a 7.5-MHz trans-
ducer probe connected to a Vingmed CFM 725 ultrasound
machine. An air free interface was created by interposing a
thoroughly de-aired ultrasound gel-filled sterile latex glove
between the probe and the vascular surface. Valvular function
was assessed by color Doppler and by continuous or pulsed-
wave Doppler. Transvalvular pressure gradients were calcu-
lated from the maximal flow velocity across the valve as deter-
mined by continuous-wave Doppler. The conduit (native or
graft) diameter, cardiac output (CO), ejection fraction (EF),
time velocity integral of pulsed wave Doppler (PWTVI), time
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Fig. 1. Photograph and schematic representation of the ascending
aorta to desending thoracic aortic bypass with the composite valved
conduit which was constructed intraoperatively.
DAO, Descending aorta; V, Position of valve; G, Graft.Animal Experimental Model for Mechanical Valve 39
velocity integral of continuous wave Doppler (CWTVI), left
ventricular end diastolic dimension (LVEDD), left ventricular
end systolic dimension (LVESD), stroke volume (SV), and
effective orifice area (EOA) were calculated. Preoperative base-
line cardiac output prior to median sternotomy was obtained
by using the thermodilution technique with the Swan Ganz
Catheter. Subsequent cardiac output measurements through
both the native aortic valve and the graft were calculated di-
rectly by echocardiography using the 2D Doppler technique.
The time velocity integral of forward systolic flow was deter-
mined by pulsed Doppler at the left ventricular outflow tract.
This value was then multiplied by the cross sectional area to
obtain the stroke volume. PWTVI or CTVI, measures of flow
velocity, were used to calculate the cardiac out-put according
to the following formula; 
Flow (Q)=Area (A)×velocity (V)
Cardiac output (CO)=Q×Heart rate/min 
Echocardiographic data were collected preoperatively, post-
operatively before drug infusion (control) and postoperatively
after the infusion of dobutamine at 10 and 20  g/kg/min. 
Statistical analysis
All data are expressed as means±standard deviation (SD).
The statistical package, SAS 6.12 (SAS Institute Inc., Cary
North Carolina, U.S.A.) was used to perform the analyses.
Echo data were compared using the Wilcoxon signed rank
test between the native aortic valve and prosthetic valve. Mixed
analysis was used to detect significant changes in dobutamine
stress test results. A p value of less than 0.05 was considered
statistically significant. 
RESULTS
The results of the hemodynamic evaluation are summarized
in Table 1. Measurements of the heart rate, cardiac output,
transvalvular Vmax (m2/sec), peak gradient (PG)max (mmHg),
and effective orifice area (EOA cm2) are shown. No significant
differences were detected in, cardiac output, heart rate, and
measured flow through the native aortic and prosthetic valves
(p=ns). The transvalvular pressure gradient across the prosthetic
valve was documented when it was noted that the difference
in the calculated cardiac output between the native aortic
annulus and the graft was negligible. The cardiac output and
the heart rate increased equally in both the native and the pros-
thetic valves in a dobutamine dose dependent manner.
As the prosthetic valvular diameter was smaller than that
of the native aortic valve, the mean EOA was also smaller (p<
0.05). Accordingly, Vmax and PG in the resting state were sig-
nificantly higher in the composite valved conduit than in the
native aortic valve (p<0.05), and this difference was accentu-
ated by incremental dobutamine infusion. Dobutamine in
excess of 10  g/kg/min significantly increased Vmax and PG
versus the resting state in both native and prosthetic valves.
Further increase in the dobutamine dosage to 20  g/kg/min
produced a further increase in Vmax and PG in the prosthetic
valve, but not in the native aortic valve.
DISCUSSION
One of the prerequisites of developing a new cardiac valvu-
lar prosthesis is a successful pre-clinical large animal series.
An appropriate animal model may provide information on
valve performance, safety, and in vivo hemodynamics (1, 5).
However, no suitable animal model is available that can yield
such information for a prosthetic aortic valve. Many animal
models have been used with variable results. These include
sheep, goats, dogs, pigs, calves and primates (6). However,
due to the unique limitations of each preclinical model, it is
imperative to develop an appropriate animal model that best
suits the purposes of the experiment at hand (7). The physical
size and the rapid growth rate of calves present problems for
postoperative husbandry and non-invasive valvular functional
assessment (8, 9). Goats have been found to be a good model
for valve testing, but their availability is often limited (10).
The relative susceptibility of dogs to sepsis and thrombosis
has marked these animals as less than optimal (11). Sheep
(Ovis aris) are widely used for testing prosthetic cardiac valves.
They have many favorable characteristics for prosthetic valve
Native aortic
valve
Prosthetic
aortic valve
p value
Preoperative 
Cardiac output (L/min) 4.6 ±1.2 -
Vmax (m
2/sec) 1.2 ±0.2 -
PGmax (mmHg) 6.1 ±2.0 -
EOA (cm
2) 2.2 ±0.6 -
Postoperative CO (L/min)
Cardiac output (L/min) 4.5 ±1.4 4.3 ±1.4 NS
Vmax (m
2/sec) 1.2 ±0.2 1.6 ±0.5 p<0.05
PGmax (mmHg) 6.3 ±6.2 11.7 ±7.0 p<0.05
EOA (cm
2). 9 ±0.5 1.4 ±0.5 p<0.05
Postop Dobutamine 10  g/kg/min
Cardiac output (L/min) 5.2 ±1.6 4.2 ±1.3 NS
Vmax (m
2/sec) 1.6 ±0.5 2.1 ±0.7 p<0.05
PGmax (mmHg) 12.8 ±11 21.0 ±15 p<0.05
EOA (cm
2) 1.9 ±0.8 1.6 ±0.8 p<0.05
Postop Dobu 20  g/kg/min
Cardiac output (L/min) 5.4 ±2.0 5.0 ±2.5 NS
Vmax (m
2/sec) 2.1 ±0.4 2.4 ±1.0 p<0.05
PGmax (mmHg) 16.1 ±7 27.1 ±22 p<0.05
EOA (cm
2) 1.9 ±0.6 1.4 ±0.6 p<0.05
Table 1. Postoperative echocardiographic data of aortic valve
and new heart valve
Vmax, maximal velocity; PGmax, maximum pressure gradient; EOA, effective
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testing, as their blood pressures, heart rates, cardiac outputs
and intra-cardiac pressures are similar to humans (12). Stan-
dard cardiopulmonary bypass techniques and anesthesia with
minor modifications are possible in these animals without
difficulty (7). However, the sheep is costly and not readily
available in Korea. In addition, the short length of the ascend-
ing aorta, which is a common feature of cloven-footed animals
(calves, sheep, and goats), gives way to the aortic bifurcation
a short way downstream of the aortic valve. Consequently,
prosthetic implantation directly into the aortic annulus is
technically challenging (13, 14). The pig is more advantageous
in terms of cost and availability, but it too shares the limita-
tions of cloven footed animals of having a short ascending
aortic trunk, a tendency to develop cardiopulmonary bypass
complications, and presenting difficulties in terms of access-
ing the peripheral venous circulation, management and han-
dling (7, 13, 15-17). Nevertheless, numerous reports on me-
chanical heart valves have been based on data derived from the
pig (2, 13, 18, 19). After a careful deliberation of various ani-
mal studies, we selected the pig for the current study. 
Thus we undertook the current study to develop a cost effi-
cient, reliable animal model that allows a relatively simple site
specific hemodynamic assessment of mechanical prosthetic
devices in the arterial environment.
During the early part of the current experiment, several
animals died of arrhythmias varying from atrial fibrillation
with intractable rapid ventricular response to frank ventricular
fibrillation. These animals were excluded from the current
data and only data from those animals (n=10) with the final
model were assessed. Ventricular fibrillation developed in three
animals immediately after mechanical ventilator application.
These animals did not receive any cardiac manipulation. In
another animal, tension pneumothorax developed during tra-
cheostomy after which ventricular fibrillation occurred. In yet
another animal, ventricular fibrillation occurred after partial
ascending aortic clamping. It is speculated that a sudden in-
crease in ventricular afterload resulting from the cross clamp
caused the ventricular fibrillation. The side-biting clamp may
understandably produce supravalvular aortic stenosis in an
unpredictable manner with variable acute after-load augmen-
tation. Intolerable levels of this sudden unprotected afterload
increase may have been the cause of death. Subsequently, to
relieve the afterload build up, a temporary bypass shunting
of the proximal ascending aorta, proximal to the cross clamp
to the femoral artery, was performed. The proximal decom-
pression afforded by this temporary shunt proved to be a key
modification, and one that led to the success of the subsequent
trials. The use of an artery to artery shunt as a means of par-
tially bypassing the aorta with a heparin coated shunt is not
a novel concept. Aorto-femoral shunting for thoracic aortic
and great vessel procedures was described by Gott and col-
leagues (20), and the feasibility of implanting an aortic
valvular device in the descending thoracic aorta to treat left
ventricular outflow tract obstruction with an apicoaortic con-
duit was described by Norman et al. (21). The concepts under-
lying these ideas led to the final design of the current exper-
imental model, which involved the use of a composite valved
conduit to bypass the aorta from the proximal aorta to the dis-
tal aorta with the aid of an aorto-femoral bypass shunt.
With the current model, a site-specific functional evaluation
of valvular prostheses without cardiopulmonary bypass in the
high pressure arterial environment is possible Furthermore,
the current model has the potential for successive testing of
different valve unit types in a single animal in a cost efficient
manner, i.e., one valve can simply be replaced by another be-
tween the two grafts. However, despite these purported advan-
tages, the hemodynamic data must accurately reflect the actual
hemodynamic performance of the valvular prosthesis being
tested. The prosthetic valve that was used in this particular
experiment had a small and fixed orifice, the latter of which
is a common trait of mechanical prostheses. Consequently, a
steeper Vmax and pressure gradient increase were observed in
the prosthetic valve as compared to the native valve. This was
especially evident with  dobutamine increment (Table 1). With
the native aortic valve serving as the control in each animal,
direct hemodynamic assessments and comparisons with the
native aortic valve were possible, as the cardiac output and
heart rate remained constant when the respective hemodynam-
ic data were being obtained from each site. Although some
obligatory sharing or diversion of blood flow to the arch ves-
sel during the hemodynamic evaluation of the composite valved
conduit after proximal thoracic aortic cross clamping was in-
evitable, the differences in the measured cardiac output and
flow between the native aortic valve and the valved conduit
became insignificant once equilibrium had been reached be-
tween the arch vessel and the valved conduit. Therefore, it is
our contention that the current model is suitable as a site-spe-
cific model for the hemodynamic assessment of valvular pros-
theses in the aortic position.
In terms of limitations, although some sharing of blood
flow with the arch vessels during distal aortic clamping was
unavoidable during the hemodynamic assessment of the pros-
thetic valve, the stated objectives of the study were fully satis-
fied as the differences in the cardiac output between the native
valve as compared with the prosthetic valve were insignificant.
Therefore, conclusions derived from the direct hemodynamic
comparison of the prosthetic and native aortic valves in the
current animal study are believed to be valid. The question
of whether the current model should be regarded as being site
specific is open to debate as the valvular device was actually
implanted in a site other than the actual aortic annulus. How-
ever, it is our contention that functionally, this model is site
specific, as the prosthetic aortic valve is continually subjected
to the stressors of the high pressure systemic arterial system as
is the annulus of the native aortic root. Issues regarding dura-
bility, thrombogenicity, calcification and other long term mo-
des of valve failure are beyond the scope of the current model,
as these parameters should be persued through a chronic ani-mal series. Nevertheless, the current model proved useful at
acquiring acute hemodynamic data relating to valve function.
In conclusion, the current model was found suitable for
acquiring essential information on the hemodynamic perfor-
mance of a valvular prosthesis, and cost and time efficient by
obviating the cardiopulmonary bypass and by offering the
potential for multiple valve testing in a single large animal.
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